Human IFIT3 (Interferon-Induced Protein With Tetratricopeptide Repeats 3) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-01477P

SDS-PAGE analysis of Human IFIT3 (Interferon-Induced Protein With Tetratricopeptide Repeats 3) - Recombinant Protein, CAT# BLT-01477P, showing >85% purity under 15% SDS-PAGE (Reduced)
Human IFIT3 (Interferon-Induced Protein With Tetratricopeptide Repeats 3) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-01477P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human Interferon-induced with tetratricopeptide repeats 3(IFIT3) Protein |
Product Overview | This recombinant human Interferon-induced with tetratricopeptide repeats 3(IFIT3) protein includes amino acids 1-490aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | O14879 |
Recommended Name | Interferon-induced protein with tetratricopeptide repeats 3 |
Gene Name | IFIT3 |
Synonyms | Interferon-induced protein with tetratricopeptiede repeats 3 isoform a, CIG-49, GARG-49, IFI60, IFIT |
Species | Human |
Predicted Molecular Mass | 58.4 kDa |
Expression System | E.coli |
Expression Range | 1-490aa |
Tag | N-6His |
Purity | >85% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Immunology |
Target Function | IFN-induced antiviral protein which acts as an inhibitor of cellular as well as viral processes, cell migration, proliferation, signaling, and viral replication. Enhances MAVS-mediated host antiviral responses by serving as an adapter bridging TBK1 to MAVS which leads to the activation of TBK1 and phosphorylation of IRF3 and phosphorylated IRF3 translocates into nucleus to promote antiviral gene transcription. Exhibits an antiproliferative activity via the up-regulation of cell cycle negative regulators CDKN1A/p21 and CDKN1B/p27. Normally, CDKN1B/p27 turnover is regulated by COPS5, which binds CDKN1B/p27 in the nucleus and exports it to the cytoplasm for ubiquitin-dependent degradation. IFIT3 sequesters COPS5 in the cytoplasm, thereby increasing nuclear CDKN1B/p27 protein levels. Upregulates CDKN1A/p21 by downregulating MYC, a repressor of CDKN1A/p21. Can negatively regulate the apoptotic effects of IFIT2. |
Subcellular Location | Cytoplasm. Mitochondrion. |
Protein Family | IFIT family |
Tissue Specificity | Expression significantly higher in peripheral blood mononuclear cells (PBMCs) and monocytes from systemic lupus erythematosus (SLE) patients than in those from healthy individuals (at protein level). Spleen, lung, leukocytes, lymph nodes, placenta, bone m |